CONTROVERSIAL ROLE OF ANTIPSYCHOTICS IN THE TREATMENT OF ALZHEIMER’S DISEASE
Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2013, Vol 1, Issue 4
Abstract
Antipsychotics are the commonly prescribed drugs in the treatment of Alzheimer’s disease, which is the most common form of dementia. Atypical antipsychotics are an effective short-term (6-12 weeks) treatment in relieving the depression, psychotic symptoms (hallucinations and delusions) and behavioral disturbances (physical and verbal aggression, motor hyperactivity, repetitive mannerisms and activities, and combativeness). But several placebo studies & clinical based evidences which recorded the deaths of the patients concluded that this medication nearly doubles the risk of death in patients over two to three years by developing cerebrovascular adverse events, upper respiratory infections, oedema or extra pyramidal symptoms. The use of selective serotonin reuptake inhibitors (SSRI’s), Nor- epinephrine reuptake inhibitors (NERI’s) and Tricyclic antidepressants (TCA’S) may relieve depression but still they are associated with serious adverse effects such as insomnia, agitation, confusion and GI adverse effects. So there is a need for applying non-pharmacological treatment i.e. Psychotherapy rather than the Pharmacotherapy in minimizing the symptoms & anticipates further research in developing the appropriate medication, alternative to the antipsychotics which minimizes the suffering of the patient. Typical antipsychotics were the first generation of the drugs aimed to treat psychosis by antagonizing D2 receptors. As a result, they reduce dopaminergic neurotransmission in the four dopamine pathways. Typical Antipsychotics include Chlorpromazine, Chlorprothixene, and Haloperidol etc. Atypical Antipsychotics are the drugs which not only block dopamine receptors but also serotonin receptors.Risperidone, Olanzapine, Quetiapine, Aripiprazole, Clozapine, Ziprasidone include Atypical Antipsychotics.
Authors and Affiliations
Mahesh G, G Praveen kumar
Keywords
Related Articles
- EP ID EP33106
- DOI -
- Views 355
- Downloads 0
Formulation and in-vitro evaluation of Divalproex sodium sustained release matrix tablets
Divalproex sodium 250 mg sustained release tablets were developed by using polymers like PVPK 30, HPMC K4M, HPMC K100M, Ethyl cellulose 45 CPS and Ethyl cellulose 20 CPS. Nine formulations were prepared with varying co...
Development of RP-HPLC method for the estimation of Thioridazine in pharmaceutical dosage form
A rapid and precise reverse phase high performance liquid chromatographic method has been developed for the validated of Thioridazine, in its pure form as well as in tablet dosage form. Chromatography was carried out o...
DEVELOPMENT AND VALIDATION OF PEMETREXED BY RP-HPLC METHOD IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORMS
A simple rapid, accurate, precise and reproducible validated reverse phase HPLC method was developed for the determination ofCeftazidimepentahydrate and Tazobactam sodium in bulk and pharmaceutical dosage forms. The qu...
EFFECTIVE HYPOGLYCEMIC ACTION OF METFORMIN COMBINATIONS AGAINST DEXAMETHASONE INDUCED DIABETES MELLITUS IN RATS
Diabetes mellitus is a chronic metabolic disorder occurs due to the damage of β-cells of islets of Langerhans in pancreas. In general patients suffering for diabetes mellitus always use the medicines, apart from the me...
Design and development of Telmisartan transferosomes
The aim of this research activity is to formulate Soyalecithin based transfersomal nanoparticles for percutaneous administration of Telmisartan for better management against cardiovascular diseases. The I.R peaks obtai...